India, July 10 -- The following biotech companies climbed to 52-week highs on July 9, 2026, driven by key catalysts like encouraging regulatory updates and clinical trial milestones.
First Tracks Biotherapeutics Inc. (TRAX)
First Tracks Biotherapeutics, a clinical-stage biotechnology company, on Thursday hit a 52-week high with a 55.99% surge in share price, to end the day at $32.40.
The company, which specialises in developing therapies for autoimmune diseases, debuted on the Nasdaq Stock Exchange in April 2026.
Spun out from AnaptysBio, First Track saw significant progress in the first quarter of the financial year, including the initiation of Phase 1 trials evaluating the ANB033 and ANB101 therapies for celiac disease, eosinophilic e...